Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

954 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.
Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, Bhatt DL, Cattaneo M, Collet JP, Cuisset T, Gachet C, Montalescot G, Jennings LK, Kereiakes D, Sibbing D, Trenk D, Van Werkum JW, Paganelli F, Price MJ, Waksman R, Gurbel PA; Working Group on High On-Treatment Platelet Reactivity. Bonello L, et al. Among authors: cattaneo m. J Am Coll Cardiol. 2010 Sep 14;56(12):919-33. doi: 10.1016/j.jacc.2010.04.047. J Am Coll Cardiol. 2010. PMID: 20828644 Free article.
ADP receptors and clinical bleeding disorders.
Cattaneo M, Gachet C. Cattaneo M, et al. Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2281-5. doi: 10.1161/01.atv.19.10.2281. Arterioscler Thromb Vasc Biol. 1999. PMID: 10521355 Review.
Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors.
Cattaneo M, Lecchi A, Lombardi R, Gachet C, Zighetti ML. Cattaneo M, et al. Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):E101-6. doi: 10.1161/01.atv.20.11.e101. Arterioscler Thromb Vasc Biol. 2000. PMID: 11073862
The platelet ADP receptors.
Cattaneo M, Gachet C. Cattaneo M, et al. Haematologica. 2001 Apr;86(4):346-8. Haematologica. 2001. PMID: 11325637 Review. No abstract available.
Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
Hechler B, Magnenat S, Zighetti ML, Kassack MU, Ullmann H, Cazenave JP, Evans R, Cattaneo M, Gachet C. Hechler B, et al. Among authors: cattaneo m. J Pharmacol Exp Ther. 2005 Jul;314(1):232-43. doi: 10.1124/jpet.105.084673. Epub 2005 Mar 25. J Pharmacol Exp Ther. 2005. PMID: 15792995
The P2 receptors in platelet function.
Hechler B, Cattaneo M, Gachet C. Hechler B, et al. Among authors: cattaneo m. Semin Thromb Hemost. 2005 Apr;31(2):150-61. doi: 10.1055/s-2005-869520. Semin Thromb Hemost. 2005. PMID: 15852218 Review.
954 results